Drugs / EuHZV
last change May 2026 re-read 2 minutes ago

EuHZV

Vaccine

Developed for
herpes zoster
Investigated by
EuBiologics Co.,Ltd

Trials 1 · a red edge is where a trial was stopped

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06409494 Jul 2024 → Jul 2025 overdue herpes zoster EuBiologics Co.,Ltd Active not recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EuHZV ClinicalTrials.gov intervention name — accepted as the source's own label NCT06409494
Modality Vaccine “Herpes Zoster Vaccine EuHZV” NCT06409494